Navigation Links
Anesthesiologists Use Caldolor® To Provide Preemptive Pain Control for Surgical Patients at U.S. Medical Centers
Date:3/2/2011

ing surgery. Reduction in opioid use could reduce opioid-related side effects such as sedation, nausea, vomiting, cognitive impairment and respiratory depression.

William Weisberg, D.O., anesthesiologist and medical director at the Surgery Center at Coral Springs in Coral Springs, Florida, has also seen improved post-surgical outcomes by administering Caldolor to patients at induction of anesthesia. "Initiating Caldolor's analgesic and anti-inflammatory properties prior to surgery minimizes the cascade of pain and inflammation, which is resulting in improved pain relief in the 24 hour period following surgery," said Dr. Weisberg. "This method of addressing pain before it occurs coupled with Caldolor's ability to achieve better pain control than opioids alone translates to less patient pain and a lower requirement for opioids. Our use of opioid rescue in the PACU (post-anesthesia care unit) has decreased, and incorporation of Caldolor into our multi-modal pain management model has led to increased patient satisfaction."

In clinical trials, Caldolor has demonstrated pain relief above and beyond that which was provided by opioids alone, while also reducing opioid use. A published study, entitled "A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial of Intravenous-Ibuprofen (IV-Ibuprofen) for Treatment of Pain in Post-Operative Orthopedic Adult Patients," appeared in the August 2010 edition of the peer-reviewed journal Pain Medicine, and concluded that dosing Caldolor at induction of analgesia as well as post-operatively is effective in treating pain and reducing morphine use in adult patients. This study provides safety and efficacy data supporting use of Caldolor in surgical patients not only during recovery, but also when administered prior to surgery.

"In the practice of acute pain medicine, reducing reliance on opioids is a strategic imperative," said Jonathan S. Jahr, M.D., Co-Editor of The Essence of Analgesia and Analg
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting
2. AcelRx Programs to be Featured in Oral Presentations at the American Society of Anesthesiologists 2009 Annual Meeting
3. Over 20 New Clinical Studies Presented on Masimo Noninvasive Patient Monitoring Technologies at the American Society of Anesthesiologists Annual Meeting
4. Pre and Post-Operative Use of Caldolor® (Ibuprofen) Injection Significantly Reduces Pain and Opioid Use in Newly Published Study
5. Caldolor® (ibuprofen) Injection Gaining Approval on Formulary at U.S. Medical Centers
6. Newly Published Data Demonstrates Caldolor® Significantly Reduces Pain and Morphine Use in Post-Operative Patients
7. Caldolor® Rapid Infusion Shown to be Safe and Well Tolerated in Newly Published Clinical Study
8. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
11. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer ... results that exceed the top end of its guidance ... of 2015 increased 10 percent to $79.5 million, compared ... of 2014. The Company,s revenue guidance range for the ... increase was driven by outperformance in the System One ...
(Date:5/6/2015)... 6, 2015  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ... development and commercialization of a once-daily, oral therapy for ... today that it will host a conference call and ... for the period ended March 31, 2015 and to ... its clinical program for aramchol. Conference ...
(Date:5/6/2015)...   Sigma-Aldrich Corporation (NASDAQ: SIAL ) a ... a $50,000 product donation to the Reproducibility Project: ... findings from recent high-impact papers in the field of ... online research marketplace Science Exchange , the non-profit ... journal eLife. The goal of the project ...
Breaking Medicine Technology:NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 2NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 3NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 4NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 5NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 6NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 7NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 8NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 9NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 10NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 11Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 2Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 3Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 2Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 3
... Reportlinker.com announces that a new ... its catalogue: Neurostimulation ... Landscape and Market Forecasts to 2017 ... Neurostimulation Devices - Global ...
... 2011 Reportlinker.com announces that a new market ... South and Central America Drug Delivery ... http://www.reportlinker.com/p0548442/South-and-Central-America-Drug-Delivery-Devices-Market-Outlook-to-2017.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory South and Central ... Summary GlobalData,s ...
Cached Medicine Technology:Reportlinker Adds Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2Reportlinker Adds Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3Reportlinker Adds South and Central America Drug Delivery Devices Market Outlook to 2017 2
(Date:5/6/2015)... (PRWEB) May 06, 2015 Dr. Vito C. ... plastic surgeons , recently completed a medical mission trip to ... on those affected by microtia and other deformities of ... April 17 and ended on April 26, Dr. Quatela and ... Microtia is a congenital deformity where the outside of the ...
(Date:5/6/2015)... The GUARDaHEART Foundation was proud to ... with the mission of providing basic living essentials and ... on Thursday, April 30th. , Through its partnership ... for the early-detection and diagnosis of heart disease, GUARDaHEART ... testing to homeless individuals and families. , “Heart ...
(Date:5/6/2015)... Mesa, Arizona (PRWEB) May 6, ... Ventures, Inc. (MAV), an investor backed Colorado cannabis ... based Phoenician Engineering subsidiary three times since first ... achieved profitability from operations, within one year of ... the end of 2014 to over 500 today ...
(Date:5/6/2015)... The American Water Resources Association (AWRA) ... prestigious Integrated Water Resources Management (IWRM) award , recognizing ... resources projects. , An IWRM approach to water resources has ... In 2014, 12 projects were nominated for the award. The ... only the 2014 AWRA IWRM Award winner - One Water, ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Doctors who ... reported what they are calling “unprecedented” tumor control in ... on the new research. Click here to read ... pembrolizumab to 25 mesothelioma patients between March and December ... in April. , “Pembrolizumab… provides robust antitumor activity in ...
Breaking Medicine News(10 mins):Health News:Dr. Vito Quatela Completes Successful 10-Day Medical Mission Trip to Hanoi, Vietnam 2Health News:Dr. Vito Quatela Completes Successful 10-Day Medical Mission Trip to Hanoi, Vietnam 3Health News:GUARDaHEART and Starbucks® Collaborate for Impactful Event to Help Homeless Families 2Health News:Cannibus Industry Start-Up Reaches Profitability While Expanding Its Proprietary Ancillary Medical Marijuana Product IP Portfolio 2Health News:Nominations Sought for Integrated Water Resources Management (IWRM) Award 2Health News:Researchers Say “Unprecedented” Mesothelioma Response Possible with Skin Cancer Drug, According to Surviving Mesothelioma 2
... tend to have fewer playmates than their non-aggressive ... comparison, non-aggressive children do better at interactions with ... findings of new research that used an important ... researchers at Arizona State University and published in ...
... emphasize physical symptoms of depression (e.g. headaches, poor appetite ... the few available empirical studies report mixed data on ... for Addiction and Mental Health (CAMH) debunks this cultural ... context when assessing a patient, leading to more accurate ...
... Mich. A new vision screening device, already shown to ... and patients a head start on treating diabetes and its ... invented by two scientists at the University of Michigan Kellogg ... stress and tissue damage that occur before the first symptoms ...
... and Inspiration to Local Heart Surgeon, PHOENIX, July ... Michael E. DeBakey, M.D. who died this past weekend ... who,performed the world,s first coronary artery bypass surgery, was ... and medical director of the,Arizona Heart Institute and Arizona ...
... many,people who have called and asked how they could help, ... with Tony Snow,s children,s education and,expenses., Jill Snow, Tony,s ... Kendall, Robbie and Kristi, as beneficiaries. Donations can,be made directly ... check,made payable to the "Tony Snow Family Trust" to:, ...
... delivers nationwide distribution for IgeaCare,s telephony-based, nurse ... AZ, July 14 /PRNewswire/ - IgeaCare Systems USA, ... a distribution agreement with Jenne,Distributors, Inc. to offer ... authorized dealers nationwide. IgeaCare provides a,telephony-based e-call and ...
Cached Medicine News:Health News:Aggressive preschoolers found to have fewer friends than others 2Health News:Culture and depression 2Health News:'Snapshots' of eyes could serve as early warning of diabetes 2Health News:'Snapshots' of eyes could serve as early warning of diabetes 3Health News:Arizona Heart Institute Remembers Heart Surgery Pioneer Dr. Michael E. DeBakey 2Health News:IgeaCare Systems USA, Inc. enters distribution agreement with Jenne Distributors, Inc. 2Health News:IgeaCare Systems USA, Inc. enters distribution agreement with Jenne Distributors, Inc. 3
Illuminated Phoroptor Refracting Instrument. Illumination is provided by a cool-running, energy efficient LEDs (Light Emitting Diodes) that light only what you need to see without affecting the darke...
Occluder and Maddox Rod...
Graham Field 10' Reversed Snellen Eye Chart....
Ultrasonic Pachymeter UP-1000 is fast, accurate corneal thickness measurements....
Medicine Products: